A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D R, Rapaport, M H, Miller, B J·2016·Molecular Psychiatry

Cited by (1,002)

Items 201–300 of 1,002

  1. Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
    Aguilar-Valles, Argel, Haji, Nabila, De Gregorio, Danilo, Matta-Camacho, Edna, Eslamizade, Mohammad J., Popic, Jelena, Sharma, Vijendra, Cao, Ruifeng, Rummel, Christoph, Tanti, Arnaud et al. · 2018 · Nature Communications
  2. A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia
    X-Y Qin, Hung‐Tsung Wu, C Cao, Y Peng Loh, Yong Cheng · 2017 · Molecular Psychiatry
  3. N ‐acetylcysteine for major mental disorders: a systematic review and meta‐analysis of randomized controlled trials
    Wei Zheng, Q.‐E. Zhang, D. Cai, Xin-Hu Yang, Y. Qiu, Gabor Sandor Ungvari, C. H. Ng, M. Berk, Yuping Ning, Yu‐Tao Xiang · 2018 · Acta Psychiatrica Scandinavica
  4. Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
    Yanni Zhan, Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Xiaofeng Lan, Xiurong Deng, Yan Xu, Bin Zhang, Yuping Ning · 2020 · Translational Psychiatry
  5. Transposable Elements and Their Epigenetic Regulation in Mental Disorders: Current Evidence in the Field
    Błażej Misiak, Laura Ricceri, Maria Malgorzata Sasiadek · 2019 · Frontiers in Genetics
  6. Sex differences in the inflammation-depression link: A systematic review and meta-analysis
    Dana Jarkas, Ally H. Villeneuve, Ayeila Daneshmend, Paul J. Villeneuve, Robyn Jane McQuaid · 2024 · Brain Behavior and Immunity
  7. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study
    Hegvik, Tor-Arne, Instanes, Johanne Telnes, Haavik, Jan, Klungsøyr, Kari, Engeland, Anders · 2018 · European Child & Adolescent Psychiatry
  8. Is depression the missing link between inflammatory mediators and cancer?
    Barbara Polityńska, Olga Pokorska, Anna M. Wojtukiewicz, Magdalena Sawicka, Marta Mysliwiec, Kenneth V. Honn, Stephanie C. Tucker, Marek Z. Wojtukiewicz · 2022 · Pharmacology & Therapeutics
  9. Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder—Preliminary Results of the PROVIT Study
    Alexandra Reiter, Susanne Bengesser, Anne-Christin Hauschild, Anna Maria Birkl-Toeglhofer, Frederike T. Fellendorf, Martina Platzer, Tanja Färber, Matthias Seidl, Lilli-Marie Mendel, Renate Unterweger et al. · 2020 · Nutrients
  10. Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review
    Evgeny A. Ermakov, Irina A. Mednova, Anastasiia S. Boiko, Valentina N. Buneva, Svetlana А. Ivanova · 2023 · International Journal of Molecular Sciences
  11. Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum
    Francesco Bavato, Flurin Cathomas, Federica Klaus, Karoline Guetter, Christian Barro, Aleksandra Maleska Maceski, Erich Seifritz, Jens Kühle, Stefan Kaiser, Boris B. Quednow · 2021 · Journal of Psychiatric Research
  12. Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis
    Saahithh Redddi Patlola, Gary J Donohoe, Declan Patrick McKernan · 2023 · Journal of Psychiatric Research
  13. Experimental medication treatment approaches for depression
    D. Ionescu, George I. Papakostas · 2017 · Translational Psychiatry
  14. Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment
    Johann Steiner, Harald Prüß, Stephan Köhler, Thomas Frodl, Alkomiet Hasan, Peter Falkai · 2018 · The World Journal of Biological Psychiatry
  15. A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone
    H. North, Christin Weissleder, J. Fullerton, Rachel E. H. Sager, M. Webster, C. Weickert · 2021 · Translational Psychiatry
  16. Vortioxetine exerts anti‐inflammatory and immunomodulatory effects on human monocytes/macrophages
    Maria Talmon, Silvia Rossi, Anna Pastore, Carlo Ignazio Cattaneo, Sandra Brunelleschi, Luigia Grazia Fresu · 2017 · British Journal of Pharmacology
  17. Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis
    Sora Park, Brian J. Miller · 2019 · Schizophrenia Research
  18. The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia
    Lulu Zhang, Hongbo Zheng, Rengrong Wu, Thomas R. Kosten, Xiangyang Zhang, Jingping Zhao · 2019 · Schizophrenia Research
  19. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions
    Hayley F. North, Jason M. Bruggemann, Vanessa Cropley, Vaidy Swaminathan, Suresh Sundram, Rhoshel Lenroot, Avril M. Pereira, Andrew Zalesky, Chad Bousman, Christos Pantelis et al. · 2021 · European Archives of Psychiatry and Clinical Neuroscience
  20. Treatment-resistant depression: molecular mechanisms and management
    Mayanja M. Kajumba, Angelina Kakooza‐Mwesige, Noeline Nakasujja, Deborah Koltai Attix, Turhan Canli · 2024 · Molecular Biomedicine
  21. Association Between Interleukin-6 and Striatal Prediction-Error Signals Following Acute Stress in Healthy Female Participants
    Michael Tilghman Treadway, Roee Admon, Amanda R. Arulpragasam, Malavika Mehta, Samuel Douglas, Gordana D. Vitaliano, David P. Olson, Jessica A. Cooper, Diego A. Pizzagalli · 2017 · Biological Psychiatry
  22. Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target
    Walter Swardfager, Marie Hennebelle, Di Yu, Bruce D. Hammock, ANTHONY J. LEVITT, Kenji Hashimoto, Ameer Y. Taha · 2018 · Neuroscience & Biobehavioral Reviews
  23. T Cell phenotype and T cell receptor repertoire in patients with major depressive disorder
    Patas, Kostas, Willing, Anne, Demiralay, Cüneyt, Engler, Jan Broder, Lupu, Andreea, Ramien, Caren, Schäfer, Tobias, Gach, Christian, Stumm, Laura, Chan, Kenneth et al. · 2018 · Frontiers in Immunology
  24. Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation
    Golam Mohammed Khandaker, Bianca P. Oltean, Muzaffer Kaşer, Claire R. M. Dibben, Rajini Ramana, Deepak Rohit Jadon, Robert Dantzer, Alasdair J. Coles, Glyn Lewis, Peter Brian Jones · 2018 · BMJ Open
  25. Future Directions for Understanding Adolescent Bipolar Spectrum Disorders: A Reward Hypersensitivity Perspective
    Lauren B. Alloy, Robin Nusslock · 2019 · Journal of Clinical Child & Adolescent Psychology
  26. Serum interleukin-6 in schizophrenia: A system review and meta-analysis
    Xin Zhou, Bo Tian, Hai-Bin Han · 2021 · Cytokine
  27. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
    David R. Goldsmith, Ebrahim Haroon, Andrew H. Miller, Jean Addington, Carrie E. Bearden, Kristin Cadenhead, Tyrone D. Cannon, Barbara A. Cornblatt, Daniel H. Mathalon, Thomas H. McGlashan et al. · 2018 · Brain Behavior and Immunity
  28. Smoking and Neuropsychiatric Disease—Associations and Underlying Mechanisms
    Omar Hahad, Andreas Daiber, Matthias Michal, Marin Kuntić, Klaus Lieb, Manfred Elmar Beutel, Thomas F. Münzel · 2021 · International Journal of Molecular Sciences
  29. Neuroinflammation in psychiatric disorders: An introductory primer
    Dunn, Geoffrey A., Loftis, Jennifer M., Sullivan, Elinor L. · 2020 · Pharmacology Biochemistry and Behavior
  30. Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression
    Norbert Müller, Daniela Krause, Rike Barth, Aye-Mu Myint, Elif Weidinger, Waltraud Stettinger, Peter Zill, Hemmo A. Drexhage, Markus Schwarz · 2019 · Journal of Affective Disorders
  31. Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression
    Kangyu Jin, Jing Lü, Zhebin Yu, Zhe Shen, Haimei Li, Tingting Mou, Yi Xu, Manli Huang · 2020 · Journal of Affective Disorders
  32. Changes in serum TNF-α, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge
    Yayan Luo, Hongbo He, Jie Zhang, Yufen Ou, Ni Fan · 2019 · Comprehensive Psychiatry
  33. The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia
    Sovannarath Pong, Rakesh Karmacharya, Marianna Sofman, Jeffrey R. Bishop, Paulo L. Lizano · 2020 · Complex Psychiatry
  34. Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder
    Brian J. Miller, David R. Goldsmith · 2020 · FOCUS The Journal of Lifelong Learning in Psychiatry
  35. Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women
    Neeti D. Mehta, Jennifer Strafford Stevens, Zhihao Li, Charles F. Gillespie, Negar Fani, Vasiliki Michopoulos, Jennifer C. Felger · 2020 · Social Cognitive and Affective Neuroscience
  36. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis
    Manuel Morrens, C. Overloop, Violette Coppens, Elke Loots, Minne Van Den Noortgate, S. Vandenameele, Marion Leboyer, Livia De Picker · 2022 · Molecular Psychiatry
  37. Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
    Kasper Recourt, Peter de Boer, Peter D van der Ark, Heike Beneš, Joop van Gerven, Marc Ceusters, Luc Van Nueten, Wayne Curtis Drevets, Anindya Bhatacharya, Michael D Browning et al. · 2023 · Translational Psychiatry
  38. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis
    Maximus Berger, Robert‐Paul Juster, Sabine Westphal, G. Paul Amminger, Bernhard Bogerts, Kolja Schiltz, Sabine Bahn, Johann Steiner, Zóltan Sarnyai · 2018 · Psychoneuroendocrinology
  39. Inflammatory Cytokines in Children and Adolescents with Depressive Disorders: A Systematic Review and Meta-Analysis
    Giulia D’Acunto, Fatuma Nageye, Junhua Zhang, Gabriele Masi, Samuele Cortese · 2019 · Journal of Child and Adolescent Psychopharmacology
  40. Neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers in different states of bipolar disorder
    Inanli, Ikbal, Aydin, Memduha, Çaliskan, Ali Metehan, Eren, Ibrahim · 2019 · Nordic Journal of Psychiatry
  41. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study
    Kuwano, Nobuki, Kato, Takahiro A., Setoyama, Daiki, Sato-Kasai, Mina, Shimokawa, Norihiro, Hayakawa, Kohei, Ohgidani, Masahiro, Sagata, Noriaki, Kubo, Hiroaki, Kishimoto, Junji et al. · 2018 · Journal of Affective Disorders
  42. What Can Mitochondrial DNA Analysis Tell Us About Mood Disorders?
    Takaoki Kasahara, Tadafumi Kato · 2017 · Biological Psychiatry
  43. Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study
    Nobuki Kuwano, Takahiro A. Kato, Masato Mitsuhashi, Mina Sato‐Kasai, Norihiro Shimokawa, Kohei Hayakawa, Masahiro Ohgidani, Noriaki Sagata, Hiroaki Kubo, Takeshi Sakurai et al. · 2018 · Journal of Affective Disorders
  44. High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder
    Yun-Rong Lu, Ying‐Bo Rao, Yu-Jian Mou, Yan Chen, Han‐Fen Lou, Yu Zhang, Dan-Xuan Zhang, Haiyan Xie, Liwei Hu, Ping Fang · 2019 · Medicine
  45. Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease
    Jonathan A. Hollander, Deborah A. Cory‐Slechta, Felice N. Jacka, Steven T. Szabo, Tomás R. Guilarte, Staci D. Bilbo, Carolyn J. Mattingly, Sheryl S. Moy, Ebrahim Haroon, Mady Hornig et al. · 2020 · Neuropsychopharmacology
  46. Complement system biomarkers in first episode psychosis
    Maja Kopczynska, Wioleta Milena Zelek, Samuel Touchard, Fiona Gaughran, Marta Di Forti, Valeria Mondelli, Robin M. Murray, Michael C. O’Donovan, B. Paul Morgan · 2017 · Schizophrenia Research
  47. Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression
    Mao, Ruizhi, Zhang, Chen, Chen, Jun, Zhao, Guoqing, Zhou, Rubai, Wang, Fan, Xu, Jingjing, Yang, Tao, Su, Yousong, Huang, Jia et al. · 2018 · Journal of Affective Disorders
  48. Increased Proinflammatory Cytokines, Executive Dysfunction, and Reduced Gray Matter Volumes In First-Episode Bipolar Disorder and Major Depressive Disorder
    Mu‐Hong Chen, Zih-Kai Kao, Wan-Chen Chang, Pei‐Chi Tu, Ju-Wei Hsu, Kai‐Lin Huang, Tung‐Ping Su, Cheng‐Ta Li, Wei-Chen Lin, Shih‐Jen Tsai et al. · 2020 · Journal of Affective Disorders
  49. Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder
    Jiaquan Liang, Hairong Liao, Caixia Xu, Xiaoling Li, Ze‐Xu Wei, Guojun Xie, Yong Cheng · 2020 · Neuropsychiatric Disease and Treatment
  50. Peripheral immune markers and antipsychotic non-response in psychosis
    Daniela Enache, Naghmeh Nikkheslat, Dina Fathalla, B. Paul Morgan, Shôn W. Lewis, Richard Drake, J.F.W. Deakin, James Walters, Stephen M. Lawrie, Alice Egerton et al. · 2021 · Schizophrenia Research
  51. The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders
    João P. Luís, Carlos J. V. Simões, Rui M. M. Brito · 2022 · International Journal of Molecular Sciences
  52. Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance
    Charles L. Raison, Andrew H. Miller · 2016 · Neuropsychopharmacology
  53. Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor
    Fabiana Maria das Graças Corsi Zuelli, Fernanda Brognara, Gustavo F. S. Quirino, Carlos Hiroji Hiroki, Rafael Sobrano Fais, Cristina Marta Del‐Ben, Luis Ulloa, Hélio César Salgado, Alexandre Kanashiro, Camila Marcelino Loureiro · 2017 · Frontiers in Immunology
  54. Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology
    Brian J. Miller, David R. Goldsmith · 2019 · Biomarkers in Neuropsychiatry
  55. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
    Miller, Andrew H., Raison, Charles L. · 2023 · Molecular Psychiatry
  56. Inflammation is associated with decreased functional connectivity of insula in unmedicated bipolar disorder
    Pan Chen, Feng Chen, Guanmao Chen, Shuming Zhong, Jiaying Gong, Hui Zhong, Tao Ye, Guixian Tang, Jurong Wang, Zhenye Luo et al. · 2020 · Brain Behavior and Immunity
  57. Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications
    Mandakh Bekhbat, Michael Tilghman Treadway, Jennifer C. Felger · 2022 · Current topics in behavioral neurosciences
  58. Gut permeability and depressive symptom severity in unmedicated adolescents
    Chadi Albert Calarge, Sridevi Devaraj, Robert Jay Shulman · 2018 · Journal of Affective Disorders
  59. Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis
    Silke Conen, Catherine J. Gregory, Rainer Hinz, Richard P. Smallman, Fabiana Maria das Graças Corsi Zuelli, J.F.W. Deakin, Peter S. Talbot · 2020 · Molecular Psychiatry
  60. Immune cell composition in unipolar depression: a comprehensive systematic review and meta-analysis
    Nina Vindegaard Sørensen, Beate Holmelund Frandsen, Sonja Orlovska‐Waast, Terkild B. Buus, Niels Ødum, Rune Haubo Bojesen Christensen, Michael E. Benros · 2022 · Molecular Psychiatry
  61. Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study
    Golam Mohammed Khandaker, Jan Štochl, Stanley Zammit, Ian Michael Goodyer, Glyn Lewis, Peter Brian Jones · 2017 · Psychological Medicine
  62. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment
    Fabiana Maria das Graças Corsi Zuelli, Camila Marcelino Loureiro, Rosana Shuhama, Helene Fachim, Paulo Rossi Menezes, Paulo Louzada‐Júnior, Valeria Mondelli, Cristina Marta Del‐Ben · 2019 · Psychological Medicine
  63. Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline
    Sinead Rooney, Anupam Sah, Michael Stefan Unger, Maria V. Kharitonova, Simone B. Sartori, Christoph Schwarzer, Ludwig Aigner, Helmut Kettenmann, Susanne A. Wolf, Nicolas Singewald · 2020 · Translational Psychiatry
  64. Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium
    Sakrajda, Kosma, Szczepankiewicz, Aleksandra · 2021 · International Journal of Molecular Sciences
  65. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid
    Buranee Kanchanatawan, Sunee Sirivichayakul, Kiat Ruxrungtham, Andre Ferrer Carvalho, M. Geffard, Heidi Ormstad, George Anderson, Michael H. J. Maes · 2017 · Molecular Neurobiology
  66. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
    Célia Fourrier, Emma Sampson, Natalie T. Mills, Bernhard Theodor Baune · 2018 · Trials
  67. Targeting the immune system in the treatment of bipolar disorder
    Joshua Daniel Rosenblat · 2019 · Psychopharmacology
  68. Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience
    Michael C. Flux, Christopher A. Lowry · 2019 · Neurobiology of Disease
  69. Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis
    Ryad Tamouza, Urs Meyer, Marianne Foiselle, Jean‐Romain Richard, Ching‐Lien Wu, Wahid Boukouaci, Philippe Le Corvoisier, Caroline Barrau, Alexandre Lucas, Hervé Perron et al. · 2021 · Translational Psychiatry
  70. Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
    Yanling Zhou, Chengyu Wang, Xiaofeng Lan, Hanqiu Li, Ziyuan Chao, Yuping Ning · 2021 · Journal of Neuroinflammation
  71. Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens
    Ji-chun Zhang, Wei Yao, Qian Ren, Chun Yang, Chao Dong, Mengyao Ma, Jin Wu, Kenji Hashimoto · 2016 · Scientific Reports
  72. Brain-immune crosstalk in the treatment of major depressive disorder
    Igor Branchi, Silvia Poggini, Lucile Capuron, Francesco Benedetti, Sara Poletti, Ryad Tamouza, Hemmo A. Drexhage, Brenda W.J.H. Penninx, Carmine Maria Pariante · 2020 · European Neuropsychopharmacology
  73. The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil–lymphocyte and platelet–lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder
    Bulut, Necati Serkut, Yorguner, Neşe, Çarkaxhiu Bulut, Gresa · 2021 · Nordic Journal of Psychiatry
  74. Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics
    Koichiro Sugimoto, Shingo Kakeda, Keita Watanabe, Asuka Katsuki, Issei Ueda, Natsuki Igata, Ryohei Igata, Osamu Abe, Reiji Yoshimura, Yukunori Korogi · 2018 · Translational Psychiatry
  75. High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
    Arafat Hussein Al-Dujaili, Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim, Michael H. J. Maes · 2020 · Schizophrenia Bulletin
  76. Novel aspects of enteric serotonergic signaling in health and brain-gut disease
    Andrew Del Colle, Narek Israelyan, Kara Gross Margolis · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  77. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
    Baune, Bernhard T., Sampson, Emma, Louise, Jennie, Hori, Hikaru, Schubert, K. Oliver, Clark, Scott R., Mills, Natalie T., Fourrier, Célia · 2021 · European Neuropsychopharmacology
  78. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder
    Evrim Özkorumak Karagüzel, Filiz Civil Arslan, Emel Uysal, Selim Demir, Demet Sağlam Aykut, Mustafa Tat, Süleyman Caner Karahan · 2018 · Comprehensive Psychiatry
  79. Potential usefulness of complete blood count parameters and inflammatory ratios as simple biomarkers of depression and suicide risk in drug-naive, adolescents with major depressive disorder
    Puangsri, Pavarud, Ninla-aesong, Putrada · 2021 · Psychiatry Research
  80. Insomnia and suicidal ideation in nonaffective psychosis
    Brian J. Miller, Carmen B Parker, Mark Hyman Rapaport, P.F. Buckley, William Vaughn McCall · 2018 · SLEEP
  81. Small cells with big implications: Microglia and sex differences in brain development, plasticity and behavioral health
    Lars H. Nelson, Angela I. Saulsbery, Kathryn M. Lenz · 2018 · Progress in Neurobiology
  82. Meta-analysis of blood cortisol levels in individuals with first-episode psychosis
    Daniel Hubbard, Brian J. Miller · 2019 · Psychoneuroendocrinology
  83. Inflammation as the Potential Basis in Depression
    Sungho Maeng, Heeok Hong · 2019 · International Neurourology Journal
  84. Hyper-inflammation of astrocytes in patients of major depressive disorder: Evidence from serum astrocyte-derived extracellular vesicles
    Xin‐hui Xie, Wentao Lai, Shu‐xian Xu, Marta Di Forti, Jingya Zhang, Mianmian Chen, Lihua Yao, Peilin Wang, Keke Hao, Han Rong · 2022 · Brain Behavior and Immunity
  85. The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation
    Wenqian Yu, Siyuan Sun, Yutong Yan, Hong Zhou, Ziyi Liu, Qiang Fu · 2025 · Frontiers in Immunology
  86. Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study
    Wei Wu, Yali Zheng, Li-ping Tian, Jianbo Lai, Chanchan Hu, Peng Zhang, Jingkai Chen, Jianbo Hu, Manli Huang, Ning Wei et al. · 2017 · Scientific Reports
  87. Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder
    Jairo Vinícius Pinto, Ives Cavalcante Passos, Diego Librenza‐Garcia, Grasiela Marcon, Maiko Abel Schneider, Joao Henrique Conte, Joao Pedro Abreu da Silva, Luiza Pereira Lima, André Quincozes‐Santos, Marcia Kauer‐Sant’Anna et al. · 2017 · Current Neuropharmacology
  88. Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment
    David Edberg, Debra Hoppensteadt, Amanda Walborn, Jawed Fareed, James M. Sinacore, Angelos E Halaris · 2018 · Journal of Psychiatric Research
  89. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels
    Lulu Zhang, Hongbo Zheng, Rengrong Wu, Furong Zhu, Thomas R. Kosten, Xiangyang Zhang, Jingping Zhao · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  90. Inflammation associated with volume reduction in the gray matter and hippocampus of older patients with bipolar disorder
    Shang‐Ying Tsai, Ariel G. Gildengers, Jung‐Lung Hsu, Kuo‐Hsuan Chung, Pao‐Huan Chen, Yu‐Jui Huang · 2018 · Journal of Affective Disorders
  91. Depression in Rheumatoid Arthritis: A Narrative Review—Diagnostic Challenges, Pathogenic Mechanisms and Effects
    Catalina Elena Ionescu, Claudiu Costinel Popescu, Mihaela Agache, Georgiana Dinache, Cătălin Codreanu · 2022 · Medicina
  92. Inflammation and cognition in severe mental illness: patterns of covariation and subgroups
    Linn Sofie Sæther, Thor Ueland, Beathe C. Haatveit, Luigi A. Maglanoc, Attila Szabó, Srdjan Djurovic, Pål Aukrust, Daniël Roelfs, Christine Mohn, Monica B E G Ormerod et al. · 2022 · Molecular Psychiatry
  93. Annual Research Review: Neuroimmune network model of depression: a developmental perspective
    Robin Nusslock, Lauren B. Alloy, Gene H. Brody, Gregory E. Miller · 2024 · Journal of Child Psychology and Psychiatry
  94. Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors
    Ragni Helene Mørch, Ingrid Dieset, Ann Færden, Elina Johanna Reponen, Sigrun Hope, Eva Zsuzsanna Hoseth, Erlend Strand Gardsjord, Monica Aas, Trude Iversen, Inge Joa et al. · 2019 · Psychological Medicine
  95. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated
    Marjolein A. M. Sneeboer, Gijsje J. L. Snijders, Woutje M. Berdowski, Alba Fernández-Andreu, Psychiatric Donor Program of the Netherlands Brain Bank (NBB-Psy), Hans C. van Mierlo, Amber Berdenis van Berlekom, Manja Litjens, René S. Kahn, Elly M. Hol et al. · 2019 · Translational Psychiatry
  96. Depressive symptoms and cognitive impairment: A 10-year follow-up study from the Survey of Health, Ageing and Retirement in Europe
    Fei-Fei Han, Hui‐Xin Wang, Jia-Jia Wu, Wu Yao, Changfu Hao, Jin-Jing Pei · 2021 · European Psychiatry
  97. Biomarkers in Child and Adolescent Depression
    Weronika Zwolińska, Monika Dmitrzak‐Węglarz, Agnieszka Słopień · 2021 · Child Psychiatry & Human Development
  98. Inflammatory Subtypes in Antipsychotic-Naïve First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization
    Dung T. Hoang, Yanxun Xu, Olivia Lutz, Deepthi Bannai, Victor Zeng, Jeffrey R. Bishop, Matcheri S. Keshavan, Paulo L. Lizano · 2021 · Brain Behavior and Immunity
  99. Prenatal maternal immune activation and brain development with relevance to psychiatric disorders
    Gustavo Scola, Angela Duong · 2017 · Neuroscience
  100. Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic health
    Inês Delgado, Lison Huet, Sandra Dexpert, Cédric Beau, Damien Forestier, Patrick Ledaguenel, Agnès Aubert, Julie Sauvant, Bruno Aouizerate, E. Magne et al. · 2018 · Psychoneuroendocrinology